Meet Julien Willard.

Willard is a clinician, health economist and former intelligence professional. He works directly with your executive team to navigate complexity, drive growth, and help make confident decisions.

Julien Willard, M.D., M.P.H., is a Russian-born American strategist in the life sciences sector. He spent over a decade as a health economist and intelligence professional. He then moved into private-sector strategy consulting.

Willard supports life sciences businesses looking to grow, scale and expand their business. He helped operate early-stage firms as well as business units within the Fortune 150 list. He works with investor groups and private equity firms.

Willard focuses on corporate strategy and operations, diligence, digital strategy, commercialization, market entry. He helps structure and fund royalty financing deals.

Most recently, Willard was Head of Strategy in IBM's life sciences group. There, he worked at the intersection of corporate and technology strategy.  Before IBM, he led a technology strategy group at Accenture. He worked with top pharmaceutical and medical devices clients.

Willard has held several leadership roles around the world. He was Head of Health Policy at Oxfam GB and a Senior Economist at the World Bank. He later became Chief of Staff at PwC's Public Sector group.

Throughout his diplomatic career, Willard served as liaison between the private sector and governments. His focus was clinical trial enablement, drug pricing, market access.

He has worked with leaders from the US, UK, Germany, Africa, the Middle East, and Asia. He helped health ministries create drug policies and public health programs. Willard helped South African leaders maintain stable drug supplies. He also co-managed and operated a large HIV vaccine development program in the U.S.

Willard has written for Harvard Business Review, World Economic Forum, the World Bank. His work has also appeared in research journals.

He received the World Bank President's Excellence Award. He teaches as a Visiting Professor at George Washington.

Willard represented Oxfam at the G20 and the United Nations. In 2024, he was the U.S. Ambassador to the World Business Angels' forum on biotech investments. He is a member of leading economics and health research organizations.